In this issue:
C-reactive protein reductions with semaglutide in patients with overweight/obesity
Impacts of PCSK1 variants on overweight/obesity
Obesity paradox in 1-year mortality of septic patients
Frailty & BMI/waist circumference
Weight reduction with a stress-eating intervention
Bidirectional relationship between weight & executive function
Rising rates of severe obesity & hospitalisations for gastrointestinal disease
Reduced oesophageal & gastric cancer after bariatric surgery
Tirzepatide better value for money than semaglutide for weight loss in type 2 diabetes
Combination GLP-1 agonist/SGLT2 antagonist therapy to reduce weight in type 2 diabetes
IGB vs. ESG for weight loss at 6/12 months
Please login below to download this issue (PDF)